Chi siamo

Novartis is reimagining medicine to improve and extend people's lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world's top companies investing in research and development. Novartis products reach more than 750 million people globally and we are finding innovative ways to expand access to our latest treatments. About 105 000 people of more than 140 nationalities work at Novartis around the world.

Indirizzo

Novartis Pharmaceuticals UK Limited
2nd Floor, The WestWorks Building, White City Place
195 Wood Lane, London, W12 7FQ
United Kingdom

Contatti

Telefono di informazioni mediche
44-1276-698370

Ore di operazione
Mon-Fri 9am-5pm GMT (excl. bank holidays)

Email di informazioni mediche
medinfo.uk@novartis.com

Effetti indesiderati e Reclami

If you get side-effects with any medication you are taking, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the information leaflet that comes in the pack.

You can report side effects via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/ (UK). By reporting side effects, you can help provide more information on the safety of your medication.

Adverse events can also be reported to Novartis patient safety online through the patient safety information (PSI) tool at https://psi.novartis.com.

Segnala un evento avverso Telefono
44-1276-698370

Segnala un evento avverso Email
medinfo.uk@novartis.com

Company website
https://www.novartis.co.uk

Facebook
https://www.facebook.com/NovartisUK/

LinkedIn
https://www.linkedin.com/company/novartis-uk-limited/

Twitter
https://twitter.com/novartisuk

Novartis Prodotto

I medicinali contrassegnati con sono soggetti a monitoraggio aggiuntivo. Ciò consentirà una rapida identificazione di nuove informazioni sulla sicurezza. Puoi aiutare segnalando eventuali effetti collaterali che potresti avere.

0-9 a b c d e f g h i j k l m n o p q r s t u v w x y z

Afinitor®
(everolimus)

Aimovig®
(erenumab)

Alomide®
(lodoxamide, trometamol)

Atectura Breezhaler®
(indacaterol, mometasone)

Azarga®
(brinzolamide, timolol )

Azopt®
(brinzolamide)

Beovu®
(Brolucizumab)

Betoptic®
(betaxolol)

Certican®
(everolimus)

Ciloxan®
(ciprofloxacin)

Co-Diovan®
(valsartan, hydrochlorothiazide)

Cosentyx®
(secukinumab)

Desferal®
(desferrioxamine)

Diovan®
(valsartan)

DuoTrav®
(travoprost, timolol )

Enerzair Breezhaler®
(glycopyrronium, indacaterol, mometasone)

Entresto®
(sacubitril, valsartan)

Estradot®
(estradiol)

Eucreas®
(vildagliptin, metformin )

Exelon®
(rivastigmine)

Exforge®
(amlodipine, valsartan)

Exjade®
(deferasirox)

Extavia®
(recombinant interferon beta-1b)

Fabhalta
(iptacopan hydrochloride monohydrate)

Famvir®
(famciclovir)

Femara®
(letrozole)

Finlee®
(dabrafenib)

Galvus®
(vildagliptin)

Gilenya®
(fingolimod)

Glivec®
(imatinib)

Ilaris®
(canakinumab)

Jakavi®
(ruxolitinib)

Kesimpta®
(ofatumumab)

Kisqali®
(ribociclib)

Kymriah®
(tisagenlecleucel)

Lamisil®
(terbinafine )

Leqvio®
(inclisiran)

Lioresal®
(baclofen)

Lucentis®
(ranibizumab)

Luxturna®
(Voretigene neparvovec)

Maxidex®
(dexamethasone)

Maxitrol®
(dexamethasone, polymyxin B, neomycin )

Mayzent®
(Siponimod)

Mekinist®
(trametinib)

Moxivig®
(moxifloxacin)

Myfortic®
(mycophenolic acid as mycophenolate sodium)

Neoral®
(ciclosporin)

Nevanac®
(nepafenac)

Onbrez®
(indacaterol)

Opatanol®
(olopatadine)

Piqray®
(alpelisib)

Prometax®
(rivastigmine)

Revolade®
(Eltrombopag)

Riamet®
(artemether, lumefantrine)

Rydapt®
(midostaurin)

Sandimmun®
(ciclosporin)

Sandostatin®
(octreotide)

Sebivo®
(telbivudine)

Seebri®
(glycopyrronium)

Signifor®
(pasireotide)

Simbrinza®
(brinzolamide, brimonidine)

Simulect®
(basiliximab)

Spexotras®
(trametinib )

Tafinlar®
(dabrafenib)

Tasigna®
(nilotinib)

Tegretol®
(carbamazepine)

Tobradex®
(tobramycin, dexamethasone )

Transiderm-Nitro®
(nitroglycerin)

Travatan®
(travoprost)

Trileptal®
(oxcarbazepine)

Tyverb®
(lapatinib)

Ultibro®
(indacaterol, glycopyrronium )

Voltarol®
(diclofenac)

Votrient®
(pazopanib)

Votubia®
(everolimus)

Xolair®
(omalizumab)

Zofran®
(ondansetron)

Zykadia®
(ceritinib)

0-9 a b c d e f g h i j k l m n o p q r s t u v w x y z
Ultimo aggiornamento: 10/09/2024